Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States
Colistin is increasingly used as an antibiotic of last resort for the treatment of carbapenem-resistant Gram-negative infections. The plasmid-borne colistin resistance gene mcr-1 was initially identified in animal and clinical samples from China and subsequently reported worldwide, including in the...
Main Authors: | José R. Mediavilla, Amee Patrawalla, Liang Chen, Kalyan D. Chavda, Barun Mathema, Christopher Vinnard, Lisa L. Dever, Barry N. Kreiswirth |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2016-08-01
|
Series: | mBio |
Online Access: | http://mbio.asm.org/cgi/content/full/7/4/e01191-16 |
Similar Items
-
Colistin Combined With Tigecycline: A Promising Alternative Strategy to Combat Escherichia coli Harboring blaNDM–5 and mcr-1
by: Yu-Feng Zhou, et al.
Published: (2020-01-01) -
Decreased Fitness and Virulence in ST10 Escherichia coli Harboring blaNDM-5 and mcr-1 against a ST4981 Strain with blaNDM-5
by: Yawei Zhang, et al.
Published: (2017-06-01) -
Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and blaNDM-5: Preparation for a Postantibiotic Era
by: Zackery P. Bulman, et al.
Published: (2017-07-01) -
Genetic characterization of blaNDM-harboring plasmids in carbapenem-resistant Escherichia coli from Myanmar.
by: Yo Sugawara, et al.
Published: (2017-01-01) -
Correction: Genetic characterization of blaNDM-harboring plasmids in carbapenem-resistant Escherichia coli from Myanmar.
by: PLOS ONE Staff
Published: (2017-01-01)